biotech startup
Longevity Science Is Overrated Experts Warn Peptide Startups
Longevity science alone does not guarantee peptide startup success. The market rewards compliant supply chains, reliable payment processing, and timing more than experimental breakthroughs. 70% of peptide startups report onboarding delays that cost months of R&D time. Medical Disclaimer: This article is for informational purposes only and does